Denosumab

Product Details:

Esentra 120mg Injection, containing denosumab, is primarily used to treat osteoporosis in postmenopausal women and men at increased risk of fractures. It also plays a role in managing certain bone-related complications of advanced cancer, such as bone metastasis. 

Here's a more detailed breakdown:

Osteoporosis:

Esentra 120mg Injection is used to treat osteoporosis, a condition characterized by weak and brittle bones. It helps to strengthen bones and reduce the risk of fractures. 

Cancer-related Bone Complications:

The medication is also used to manage complications related to bone metastasis in advanced cancer, such as fractures or pressure on the spinal cord. 

Mechanism of Action:

Denosumab, the active ingredient in Esentra, works by inhibiting a protein called RANKL, which is involved in the breakdown of bone tissue. By inhibiting RANKL, denosumab helps to increase bone mass and strength. 

Other Uses:

In some cases, it may also be used in the management of giant cell tumors of the bone that cannot be treated surgically. 

Important Considerations:

Esentra 120mg Injection is administered by a healthcare professional and should not be self-administered. 

Patients should also take adequate calcium and vitamin D supplements while on treatment. 

It is crucial to maintain good oral hygiene and to inform your doctor about any dental plans before starting treatment.